vasopressins - CISMeF

Preferred Label : vasopressins;

MeSH definition : Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.;

MeSH synonym : beta hypophamine; beta-hypophamine; antidiuretic hormones; Antidiuretic Hormone; Hormone, Antidiuretic;

CISMeF synonym : monarch brand of vasopressin; vasopressin monarch brand; american regent brand of vasopressin; american pharmaceutical brand of vasopressin; Parke-Davis brand of vasopressin (USP);

MeSH hyponym : vasopressin (USP); pitressin; Vasopressin;

Registry Number MeSH : 11000-17-2;

MeSH annotation : general or unspecified; prefer specifics; /secret: consider also INAPPROPRIATE ADH SYNDROME; general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Vasopressin;

Codes EINECS : 234-236-2;

Is substance : O;

Details

Origin ID

D014667;

UMLS CUI

C0042413;

ATC code(s)
- vasopressin (argipressin) [ATC Code]
- vasopressin and analogues [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- vasopressin [Substance BNPC]
Currated CISMeF NLP mapping
- ADH [MedDRA LLT]
- Antidiuretic hormone [MedDRA LLT]
- Antidiuretic hormone (substance) [SNOMED CT concept]
- Vasopressin [ICD-11 Extension code]
- Vasopressin [FMA entity]
- Vasopressin [LOINC component]
- Vasopressin [MedDRA LLT]
- antidiuretic hormone [SNOMED Notion]
Indexing information
- F992 peptide [MeSH Supplementary Concept]
- NOX-F37 oligoribonucleotide [MeSH Supplementary Concept]
- SK&F 105494 [MeSH Supplementary Concept]
- benzylcarbonyl-4-benzoylphenylalanyl-phenylalanyl-glutaminyl-asparaginyl-arginyl-prolyl-arginyl-3-iodotyrosinamide [MeSH Supplementary Concept]
- hydroxyphenylacetyl-methyltyrosyl-phenylalanyl-glutaminyl-asparaginyl-arginyl-prolyl-argininamide [MeSH Supplementary Concept]
Pharmacological action(s)
- antidiuretic agents [MeSH Descriptor]
- hemostatics [MeSH Descriptor]
- vasoconstrictor agents [MeSH Descriptor]
Record concept(s)
- pitressin [MeSH concept]
- vasopressin (USP) [MeSH concept]
- vasopressins [MeSH concept]
Related MeSH Supplementary Concept(s)
- AVP protein, human [MeSH Supplementary Concept]
- Avp protein, rat [MeSH Supplementary Concept]
- F-180 vasoconstrictor peptide [MeSH Supplementary Concept]
- glanduphen [MeSH Supplementary Concept]
- iodo-lin-vasopressin [MeSH Supplementary Concept]
- lidocaine, norepinephrine, vasopressin drug combination [MeSH Supplementary Concept]
- oxytocin, beta-mercapto-beta,beta-cyclopentamethylenepropionic acid-Trp(2)-Phe(3)-Ile(4)-Arg(8)- [MeSH Supplementary Concept]
- pitressin tannate [MeSH Supplementary Concept]
- preprovasopressin [MeSH Supplementary Concept]
- pressinamide [MeSH Supplementary Concept]
- pressinoic acid [MeSH Supplementary Concept]
- proAVP hormone [MeSH Supplementary Concept]
- vasopressin, (beta-mercapto-(beta,beta)-cyclopentamethylenepropionic acid)-Phe(2)-Ile(4)-Ala(9)- [MeSH Supplementary Concept]
- vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)- [MeSH Supplementary Concept]
- vasopressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-O-ethyl-Tyr(2)-Val(4)-Cit(8)- [MeSH Supplementary Concept]
- vasopressin, des-Gly- [MeSH Supplementary Concept]
- vasopressin, epsilon-hydroxy-Nle(8)- [MeSH Supplementary Concept]
- vasopressin, homo-Nle(8)- [MeSH Supplementary Concept]
- vasopressinase-altered vasopressin [MeSH Supplementary Concept]
See also
- inappropriate adh syndrome [MeSH Descriptor]
- receptors, vasopressin [MeSH Descriptor]
See also (suggested by CISMeF)
- Antidiuretic Hormone Receptor Antagonists [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- Arginine-Vasopressin [NCIt concept]
- vasopressin (argipressin) [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients